Explore the Promoter Regulation and Downstream Targets of Mir-204 to Control Tumor Progression and Lung Cancer Treatments.

2019-08-012024-05-13https://scholars.lib.ntu.edu.tw/handle/123456789/652840肺癌miR-204EGFR TKIEGFR mutationstem cellepithelial–mesenchymal transition (EMT)肺癌miR-204EGFR TKIEGFR mutationstem cellepithelial–mesenchymal transition (EMT)Explore the Promoter Regulation and Downstream Targets of Mir-204 to Control Tumor Progression and Lung Cancer Treatments.